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Regulation of acetylated low density lipoprotein uptake
in macrophages by pertussis toxin-sensitive G proteins
Stewart C. Whitman, Alan Daugherty, and Steven R. Post1
Division of Cardiovascular Medicine, Atherosclerosis Research Group, Gill Heart Institute,
University of Kentucky, L543 Kentucky Clinic, Lexington, KY 40536-0284

Abstract Class A scavenger receptors (SR-A) mediate the
uptake of modified low density lipoprotein (LDL) by macrophages. Although not typically associated with the activation of intracellular signaling cascades, results with peritoneal macrophages indicate that the SR-A ligand acetylated
LDL (AcLDL) promotes activation of cytosolic kinases and
phospholipases. These signaling responses were blocked by
the treatment of cells with pertussis toxin (PTX) indicating
that SR-A activates Gi/o-linked signaling pathways. The functional significance of SR-A-mediated Gi/o activation is not
clear. In this study, we investigated the potential role of Gi/o
activation in regulating SR-A-mediated lipoprotein uptake.
Treatment of mouse peritoneal macrophages with PTX decreased association of fluorescently labeled AcLDL with
cells. This inhibition was dependent on the catalytic activity
of the toxin confirming that the decrease in AcLDL uptake
involved inhibiting Gi/o activation. In contrast to the inhibitory effect on AcLDL uptake, PTX treatment did not alter
␤-VLDL-induced cholesterol esterification or deposition of
cholesterol. The ability of polyinosine to completely inhibit
AcLDL uptake, and the lack of PTX effect on ␤-VLDL uptake, demonstrated that the inhibitory effect is specific for
SR-A and not the result of non-specific effects on lipoprotein
metabolism. Despite having an effect on an SR-A-mediated
lipoprotein uptake, there was no change in the relative
abundance of SR-A protein after PTX treatment. These
results demonstrate that activation of a PTX-sensitive G
protein is involved in a feedback process that positively regulates SR-A function.—Whitman, S. C., A. Daugherty, and S. R.
Post. Regulation of acetylated low density lipoprotein uptake in macrophages by pertussis toxin-sensitive G proteins.
J. Lipid Res. 2000. 41: 807–813.
Supplementary key words atherosclerosis • endocytosis • cholesterol •
ACAT • class A scavenger receptor • ␤-VLDL

An early step in the formation of atherosclerotic lesions
is the accumulation of modified low density lipoprotein
(LDL), formed by oxidation of both the protein and lipid
components of LDL in the arterial wall (1 –4). Modified
LDL is taken up by macrophages via interaction with class
A scavenger receptors (SR-A). Chemically modified forms
of LDL, such as acetylated LDL (AcLDL), bind to SR-A
with high affinity and are commonly used to assess the

function of this receptor (5). In macrophages, the uptake
of AcLDL via SR-A results in excessive cholesteryl ester accumulation and leads to lipid engorgement as characteristically seen in atherosclerotic lesions (6). The role of SR-A
in mediating macrophage cholesteryl ester accumulation
during incubation with AcLDL is demonstrated by the
80% reduction in esterification in SR-A-deficient mice (7).
Moreover, SR-A deficiency decreases lesion development
in atherosclerosis-susceptible mice (8, 9). While it seems
clear that SR-A is a key component in the development
and progression of atherosclerotic lesions, the molecular
mechanisms by which SR-A function is regulated are not
well understood.
Lipoprotein receptors are primarily thought to function in cholesterol transport and are not typically associated with transmembrane signaling processes. However,
recent evidence indicates that specific lipoproteins, in
particular modified LDL, activate intracellular signaling
cascades (10–12). For example, incubation of human
monocyte/macrophage cells with AcLDL results in the activation of tyrosine kinases and protein kinase C (10). Results from other studies in isolated peritoneal macrophages indicate that AcLDL increases intracellular Ca 2⫹
and promotes the activation of cytosolic tyrosine kinases
and phospholipases (12). In these studies, signal propagation was blocked by the treatment of cells with pertussis
toxin (PTX), a highly specific inhibitor of heterotrimeric
GTP binding proteins (G proteins) of the Gi/o family (13).
Together, these results demonstrate a link between scavenger receptors and activation of PTX-sensitive G proteins.
Although AcLDL interacts with SR-A to activate G proteins, no functional consequences have been attributed to
this process. The results of the present study define the
impact of Gi/o activation on lipoprotein uptake. Overall,

Abbreviations: LDL, low density lipoprotein; AcLDL, acetylated low
density lipoprotein; SR-A, class A scavenger receptor; PTX, pertussis
toxin; ␤-VLDL, ␤ very low density lipoprotein; MPM, mouse peritoneal
macrophages; DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal
bovine serum; DiI-AcLDL, 1,1⬘-dioctadecyl-3,3,3⬘,3⬘-tetramethylindocarbocyanine perchlorate-labeled acetylated low density lipoprotein.
1 To whom correspondence should be addressed.
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our results indicate that a feedback process involving
ligand-dependent activation of a PTX-sensitive G protein
positively regulates SR-A function.

EXPERIMENTAL PROCEDURES
Chemicals
DMEM medium with l-glutamine and high glucose and heatinactivated fetal bovine serum (FBS) were purchased from
Gibco-BRL (Grand Island, NY). Pertussis toxin and the isolated
toxin B-oligomer were from Calbiochem (La Jolla, CA). Guinea
pig polyclonal anti-SR-A sera (Mac 5.2) was a generous gift from
Joseph Witztum (UCSD, CA) and rat monoclonal anti-SR-A antibody (2F8) was purchased from Serotec (Raleigh, NC). The
monoclonal anti-␤ actin antibody was obtained from Sigma (St.
Louis, MO). 1,1⬘-Dioctadecyl-3,3,3⬘,3⬘-tetramethyl indocarbocyanine perchlorate-labeled AcLDL (DiI-AcLDL) was purchased
from Biomedical Technologies Inc. (Stoughton, MA). Assay kits
for determination of total and unesterified cholesterol were purchased from Wako Pure Chemical (Richmond, TX).

Lipoprotein isolation and acetylation
LDL (d 1.019–1.063 g/ml) was isolated by sequential ultracentrifugation (14) of EDTA-anticoagulated plasma obtained
from healthy normolipidemic volunteers. LDL was dialyzed
against 0.15 m NaCl and 1 mm EDTA (pH 7.4). Acetylated LDL
(AcLDL) was prepared by chemical modification of LDL with
acetic anhydride as described by Basu et al. (15) and confirmed
by agarose gel electrophoresis and comparison to unmodified
LDL. Beta-migrating VLDL (␤-VLDL; d ⬍ 1.006 g/ml) was isolated by sequential ultracentrifugation of EDTA-anticoagulated
plasma obtained from New Zealand White rabbits maintained
on a 1.0% cholesterol-enriched diet (16). Lipoprotein preparations were sterilized by passage through 0.22-m filters and
stored at 4⬚C. Lipoprotein samples were analyzed for protein
content by the method of Lowry et al. (17).

Cell culture
Resident peritoneal macrophages were collected from 6–8week-old male outbred Cr:NIH (S) Swiss mice (NCI Charles
River) by peritoneal lavage with 5 ml ice-cold sterile saline. Cells
were resuspended in DMEM containing penicillin/streptomycin
and 10% FBS and plated at a density of 1 ⫻ 106 cells/ml. After
overnight incubation at 37 ⬚C, non-adherent cells were removed
by gently washing cells three times with serum-free DMEM. Adherent macrophages were then cultured in medium with FBS for
24 h prior to experimentation.

DiI-AcLDL association assays
Association of DiI-AcLDL was used to assess the effect of PTX
treatment on modified lipoprotein uptake. Isolated peritoneal
macrophages were treated with the indicated concentrations of
PTX (A⫹B subunits) or the toxin’s binding domain (B-oligomer)
in DMEM plus FBS for 24 h. Cells were then washed, fluorescent
lipoprotein (DiI-AcLDL, 5 g/ml) was added, and incubations
were continued for 2 h in serum-free DMEM. Unbound ligand
was removed by washing twice with ice-cold phosphate-buffered
saline (PBS, pH 7.4) and cells were fixed by incubating with
paraformaldehyde (4% in PBS, pH 7.4) for 15 min on ice. Cells
were scraped into PBS and cell-associated fluorescence was determined by fluorescence-activated cell sorting (FACS) analysis.
Data are expressed as the percent of cells displaying a fluorescent intensity within the peak defined by DiI-AcLDL association
with untreated cells.
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Cholesterol esterification assays
The incorporation of [3H]oleic acid into cholesteryl esters
was used as a measure of macrophage-mediated metabolism of
lipoproteins. Isolated peritoneal macrophages were treated with
PTX in DMEM plus FBS for 24 h. Cells were then washed, lipoproteins (␤-VLDL or AcLDL) were added, and incubations were
continued for 5 h in serum-free DMEM containing 0.9 Ci
[3H]oleic acid (Amersham, Piscataway, NJ) complexed with
fatty acid-free BSA in a molar ratio of 5:1. The cells were washed
twice with ice-cold Tris buffer (pH 7.4) and lipids were extracted by two 30-min incubations with 1 ml hexane–
isopropanol 3:2 (vol/vol) containing carrier lipid (triolein and
cholesterol palmitate). Cell proteins were solubilized in 0.5 ml
0.1 N NaOH for 16 h at room temperature and protein content
was determined using the Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA) with BSA as a standard. The lipid extracts were dried under nitrogen, resuspended in chloroform–
methanol 2:1 (vol/vol), and resolved by thin-layer chromatography with petroleum ether–diethyl ether–acetic acid 84:15:1
(vol/vol/vol). Esterified cholesterol was identified by exposure
to iodide vapor, scraped into EcoLite (ICN, Costa Mesa, CA),
and the amount of cholesteryl [3H]oleate was quantified by liquid scintillation counting using a Beckman LS 3801 counter.
Results are expressed as nanomoles of cholesteryl [3H]oleate
formed/milligram of cell protein.

Cholesterol mass assays
For determination of cholesterol mass, adherent macrophages were treated (or untreated) with PTX for 24 h, washed
with serum-free DMEM, and incubated for an additional 16 h
with the indicated lipoproteins and PTX (treated cells) in
DMEM supplemented with 5% lipoprotein-deficient serum.
Cells were washed with ice-cold Tris buffer (pH 7.4) and lipid
was extracted as described above using hexane–isopropanol
without carrier lipid (18). Cell proteins were solubilized in 0.5
ml 0.1 N NaOH for 16 h at room temperature and protein content was determined as described above. Cholesterol and cholesteryl ester content in the lipid extracts were determined as
described previously (19). Briefly, the extracted lipid was solubilized in Triton X-100 containing chloroform and converted to
an aqueous suspension. Aliquots were transferred to 96-well microtiter plates and cholesterol and cholesteryl ester content was
determined using commercial enzyme-based assay kits. Results
are expressed as micrograms of cholesterol/milligram of cell
protein.

Detection of SR-A protein
For determination of SR-A protein expression, peritoneal macrophages were incubated with or without PTX (100 ng/ml) for
24 h. Incubation medium was removed, cell lysates were prepared in reducing Laemmli buffer, proteins were resolved by
12% SDS-PAGE, and proteins were transferred to PVDF. Blots
were probed sequentially with anti-SR-A sera (Mac 5.2) and anti␤-actin antibody followed by incubation with species-specific
HRP-coupled secondary antibodies. Blots were incubated with
chemiluminescence substrate (Supersignal; Pierce, Rockford, IL)
and luminescent bands were detected using a Kodak Image Station 440.

Statistical analysis
For statistical analysis, data were analyzed by one-way ANOVA
using GraphPad Prism program. When a statistical difference
was indicated, results were analyzed with the appropriate posttest. For cholesterol esterification and mass assays, results from
PTX-treated cells were compared to untreated cells using a Bonferroni’s post-test.

RESULTS
Pertussis toxin treatment decreases DiI-AcLDL
association with macrophages
As an initial approach to determine whether Gi/o proteins regulate AcLDL interaction with SR-A, MPM were
isolated from NIH-Swiss mice and treated for 24 h with increasing concentrations of either the PTX (A⫹B subunits) or the toxin-binding domain (B-oligomer). The
B-oligomer mediates cell association and facilitates entry of
the A-subunit into the cell. The A-subunit possesses the catalytic activity required for ADP-ribosylation of ␣-subunits of
heterotrimeric Gi/o proteins, a modification that prevents
receptor-mediated activation of the G protein (13). Cells
were incubated with the fluorescent SR-A ligand, DiIAcLDL, for 2 h at 37⬚C. Unbound ligand was removed by
repeated washing, cells were fixed with paraformaldehyde, and the amount of ligand associated with cells was
determined by FACS analysis. As shown in Fig. 1, treatment
of macrophages with PTX (A⫹B subunits) substantially inhibited DiI-AcLDL association with MPM. This inhibitory
effect of PTX was maximal at a toxin concentration of 100
ng/ml (32 ⫾ 5%; n ⫽ 10) with no further increase in inhibition observed at concentrations as high as 500 ng/ml.
This concentration range is consistent with that shown
previously to specifically inhibit Gi/o function in intact
macrophages (20). Therefore, in all further experiments
PTX was used at a concentration of 100 ng/ml.

tion with high concentrations of the B-oligomer, this result is consistent with the presence of holotoxin (⭐1%) in
the B-oligomer preparation (as reported by the supplier).
These data support the conclusion that Gi/o activation is
important in regulating a significant component of
AcLDL uptake by macrophages.

Decreased AcLDL association with PTX-treated
macrophages depends on inhibition of Gi/o
The dependence of this inhibitory effect on AcLDL uptake on PTX-mediated ADP-ribosylation of the ␣-subunits
of Gi/o proteins is demonstrated by the lack of effect of
the toxin’s B-oligomer. Although minimal (⬍10%) inhibition of DiI-AcLDL association was observed after incuba-

Inhibition of Gi/o specifically decreases
AcLDL metabolism
To determine whether the decreased association of DiIAcLDL with PTX-treated macrophages reflected reduced
SR-A function, the effect of PTX treatment on the ability of
AcLDL to increase cholesteryl [3H]oleate accumulation was
quantified. Treatment of macrophages with PTX decreased
the incorporation of [3H]oleate into cholesteryl ester (Fig.
2) after incubation with AcLDL. In contrast to the inhibitory
effect on AcLDL metabolism, PTX treatment did not alter
cholesteryl [3H]oleate deposition in macrophages incubated with ␤-VLDL, a lipoprotein that stimulates cholesterol
esterification through an alternative receptor pathway. The
lack of a PTX effect on ␤-VLDL metabolism indicates that
PTX treatment does not have a general inhibitory effect on
intracellular lipoprotein trafficking and processing.
Native and modified lipoproteins are thought to internalize via receptor-mediated endocytosis in clathrincoated pits and metabolized in lysosomes (21, 22). However, it has been suggested that AcLDL internalization by
SR-A involves multiple pathways (23, 24). To confirm that
the decreased AcLDL-induced cholesteryl ester deposition in PTX-treated macrophages reflected decreased
lipoprotein internalization and not enhanced uptake via a
pathway that did not involve lipoprotein metabolism in lysosomes, lipoprotein-induced increases in cholesterol
mass were determined. PTX treatment decreased AcLDLinduced increase in total cellular cholesterol mass, but did
not alter ␤-VLDL-induced changes (Fig. 3A). The de-

Fig. 1. PTX reduces uptake of AcLDL in MPM via ADP-ribosylation
of G i/o . The association of fluorescently labeled AcLDL (DiIAcLDL) was determined in MPM that were untreated or treated for
24 h with the indicated concentration of PTX holotoxin (closed circles) or the cell-binding domain (B-oligomer, open circles) prior to
incubation with DiI-AcLDL (5 g/ml) for 2 h. The amount of fluorescence associated with cells was determined by FACS analysis.

Fig. 2. PTX treatment inhibits AcLDL-, but not ␤-VLDL-induced
cholesterol esterification in MPM. Cholesterol esterification was determined in MPM that were untreated or treated for 24 h with PTX
(100 ng/ml) prior to incubation with 50 g/ml of ␤-VLDL or
AcLDL and a [3H]oleic acid–albumin complex for 5 h. Cellular esterified cholesterol was isolated by thin-layer chromatography and
cholesteryl [3H]oleate was quantified. Histograms and bars represent mean ⫾ SEM of at least three different experiments conducted in triplicate.
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Fig. 4. Polyinosine inhibits the PTX-sensitive and insensitive
pathways of AcLDL uptake. Cholesterol esterification was determined in MPM that were incubated with the indicated concentration of polyinosine, a competitive antagonist for SR-A. AcLDL (50
g/ml) and a [ 3H]oleic acid – albumin complex was added and
cells were incubated for 5 h. Cellular esterified cholesterol was isolated by thin-layer chromatography and cholesteryl [3H]oleate was
quantified. The symbols represent the mean and the bars represent
the range of triplicate determinations from a representative experiment (for some points the bars are smaller than the symbol).

Fig. 3. PTX treatment decreases esterified cholesterol mass in
AcLDL, but not in ␤-VLDL-treated MPM. Total and unesterified
cellular cholesterol mass was determined in MPM that were untreated or treated with PTX (100 ng/ml) for 24 h prior to incubation with ␤-VLDL (10 g/ml) or AcLDL (50 g/ml) for 16 h. Cellular unesterified and total cholesterol were determined by
enzymatic kits. Esterified cholesterol mass was determined by subtraction of the unesterified mass from the total mass. Histograms
and bars represent mean ⫾ SEM (n ⫽ 3).

crease in cholesterol mass in PTX-treated cells resulted
from reduced cholesteryl ester content (Fig. 3B) and not
from a reduction in the mass of unesterified cholesterol
mass (Fig. 3C). Together, our results indicate that activation of Gi/o proteins is specifically involved in regulating
SR-A-mediated uptake. Further, our data indicate that
SR-A-mediated uptake of AcLDL involves two pathways:
one that is PTX-sensitive and the other PTX-insensitive.
Gi/o inhibition decreases AcLDL uptake via SR-A
Although AcLDL is a selective ligand for SR-A, macrophages may express multiple scavenger receptor types
810
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that bind AcLDL. Therefore, it is possible that the decreased AcLDL uptake after PTX treatment reflects an inhibition of one or more receptor types. To test this possibility, AcLDL uptake was assessed in the absence or
presence of the selective SR-A antagonist, polyinosine
(25). As shown in Fig. 4, polyinosine reduced AcLDLinduced cholesteryl [3H]oleate deposition to basal levels,
indicating that AcLDL uptake by MPM is mediated by SRA. Similarly, incubations of macrophages isolated from
NIH-Swiss mice with the specific SR-A monoclonal antibody (2F8) reduced AcLDL uptake to ⭐5% of control
values (26). Given the extent to which SR-A mediates
AcLDL uptake in MPM, it appears that Gi/o specifically
regulates SR-A function in macrophages. Based on these
results, we conclude that SR-A-mediated activation of a Gi/o
protein enhances internalization of AcLDL, suggesting a
novel mechanism for regulating SR-A function.
PTX treatment does not alter SR-A expression
One possible explanation for the decreased uptake of
AcLDL after PTX treatment is decreased SR-A expression.
To assess this possibility, total cell lysates were prepared
from MPM treated with PTX and cellular protein resolved
by SDS-PAGE. SR-A was detected by immunoblotting
using a SR-A-specific polyclonal antisera (Mac5-2). As
shown in Fig. 5, treatment of cells with PTX did not alter
the relative abundance of immunodetectable SR-A present
in MPM cell lysates. The amount of ␤-actin present in
each cell extract was used to normalize the abundance of
SR-A. Thus, Gi/o inhibition decreases the uptake of AcLDL
by a mechanism that does not involve decreased expression of SR-A.

Fig. 5. Pertussis toxin treatment does not alter the relative abundance of immunodetectable SR-A in MPM. Duplicate isolates of
MPM were incubated with or without pertussis PTX (100 ng/ml)
for 24 h. Cell protein was separated by 12% SDS-PAGE and proteins
were transferred to PVDF. Blots were probed sequentially with antiSR-A antisera and anti-␤-actin antibody followed by incubation with
species-specific HRP-coupled secondary antibodies. Bands were detected by chemiluminescence.

DISCUSSION
The finding that AcLDL, but not ␤-VLDL, uptake by
macrophages is PTX sensitive indicates a specific association between SR-A function and Gi/o proteins. Although
previously suggested that PTX-sensitive signaling pathways
are activated by modified lipoproteins, the functional significance of activating these pathways on SR-A function
has not been addressed. Our results demonstrate that inhibiting these signaling pathways with PTX substantially
reduces the uptake of the scavenger receptor ligand
AcLDL. In contrast, PTX treatment did not affect the uptake of ␤-VLDL. In addition, polyinosine and the SR-Aspecific antibody 2F8 completely attenuated AcLDL uptake, indicating that decreased AcLDL uptake after PTX
treatment resulted from the specific inhibition of SR-A. Together, our data indicate that activation Gi/o is involved in a
feedback process that enhances SR-A-mediated uptake.
Cell-surface receptors that interact with heterotrimeric G
proteins generally have a characteristic seven-membrane
spanning topology. However, recent studies indicate that
other structurally diverse receptors can also interact with G
proteins. For example, the LDL receptor-related protein
(LRP) was recently shown to interact with and activate a G
protein (11). Likewise, the thrombospondin receptor
(CD47), a member of the IgG receptor superfamily, and
the glycosylphosphatidylinositol (GPI)-anchored glycoproteins CD14 and CD59 were shown to activate PTX-sensitive
G proteins (27–29). Like these receptors, the putative
structure of SR-A is very different from the characteristic
seven-membrane spanning topology of receptors that signal through Gi/o proteins. Nevertheless, our results indicate that SR-A interacts with Gi/o and that Gi/o signaling
pathways are activated in response to SR-A ligand.
Although it is commonly thought that SR-A internalizes
lipoproteins via receptor-mediated endocytosis in clathrincoated pits, previous results suggest that AcLDL uptake involves multiple processes. By assessing the rate of 125Ilabeled AcLDL internalization, Fong, Fong, and Cooper
(23) showed that uptake involved two kinetic processes:
the first with an apparent t1/2 ⬃4 min and the second with
a t1/2 ⬎30 min. Consistent with these findings, Zha et al.
(24) demonstrated that macrophages internalize AcLDL

via two distinct pathways. One pathway is shared by the
LDL receptor and likely represents a classic clathrincoated pit endocytic process. The second pathway accounted for ⬎40% of the AcLDL uptake and was distinct
from that used by LDL. Uptake via this pathway involved
prolonged cell-surface localization of the AcLDL particle
within a region of membrane displaying microvilli-like
projections. While these authors did not exclude the possibility that the second pathway involved clathrin-coated
pits, they demonstrated that uptake via both pathways was
mediated by SR-A. Although it has yet to be determined
whether lipoprotein uptake by either of these uptake
pathways is PTX sensitive, our results demonstrating that
SR-A mediates AcLDL uptake by both Gi/o-dependent and
-independent pathways suggest such a possibility.
Internalization of cell surface receptors is largely dependent on internalization signals contained within the cytoplasmic domain. Several sequences that regulate receptor
endocytosis have been identified including: a) tyrosinecontaining motifs with the consensus of YXX⌽, where ⌽
represents a bulky hydrophobic residue (e.g., NPXY in the
LDL receptor (30), and YXRF in the transferrin receptor
(31, 32)); b) dileucine motifs (e.g., insulin receptor (33,
34), Glut4 transporter (35), and IgG Fc receptor (36)); c)
clusters of acidic amino acids (e.g., furin receptor (37, 38));
d) ␤-arrestin binding domains (e.g., G protein-coupled receptors)(39); and e) phosphorylation sites (e.g., G proteincoupled receptors, tyrosine kinase receptors (38, 40 –47)).
SR-A proteins, of which there are two splice variants
(Types I and II), are trimeric membrane proteins with
each monomer comprised of six (Type I) or five (Type II)
distinct domains. Each monomer of the SR-A protein has
a short (50 amino acid) amino-terminal cytoplasmic tail
(5, 48, 49). To date, an internalization motif has not been
identified in the cytoplasmic portion of SR-A and little is
known regarding the cytoplasmic signals that regulate
macrophage uptake of SR-A ligands.
The mechanisms by which Gi/o signaling pathways modulate SR-A-mediated lipoprotein uptake are not clear, but
may represent an important regulatory process in the uptake of modified lipoprotein and in the development of
atherosclerosis. Based on our current understanding
of receptor endocytosis and G protein regulation of this
process, at least three possible explanations can be identified. First, Gi/o proteins may regulate the localization of
SR-A to the plasma membrane. Previous results have associated the redistribution of SR-A from an intracellular
pool to the plasma membrane with an increase in the uptake of modified lipoprotein (50). A second mechanism
that is consistent with our results is that interaction of
SR-A with a Gi/o protein enhances the ability of receptor
to bind ligand. A reduced ability of SR-A to bind AcLDL
was observed previously after treatment of macrophages
with the protein phosphatase inhibitor okadaic acid (51).
The reduced binding appeared to reflect receptor sequestration and/or inactivation, but did not result from a loss
of cell-surface receptors. Thus, our results would be consistent with the notion that interaction of SR-A with Gi/o
regulates receptor sequestration/inactivation. Third, acti-
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vation of a signaling cascade by Gi/o proteins may regulate
the process of receptor-mediated endocytosis. The finding
that inhibition of intracellular protein kinases decreases
AcLDL internalization (51) is of particular interest because AcLDL reportedly increases protein kinase activity
through activation of a PTX-sensitive G protein (10, 12,
52). Thus, Gi/o-mediated activation of one or more protein
kinases might feedback to enhance SR-A internalization. In
summary, our results indicate that a feedback process involving the ligand-dependent activation of a PTX-sensitive
G protein positively regulates SR-A-mediated lipoprotein
uptake.
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